MEZAVANT

Serial Number 98631731
688

Registration Progress

Application Filed
Jul 3, 2024
Under Examination
May 20, 2025
Approved for Publication
Mar 25, 2025
Published for Opposition
Mar 25, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Nov 20, 2025 123 days

Trademark Image

MEZAVANT

Basic Information

Serial Number
98631731
Filing Date
July 3, 2024
Published for Opposition
March 25, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
688
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

Nogra Pharma Limited

11
Address
33, Sir John Rogerson's Quay
Dublin 2
IE

Ownership History

Nogra Pharma Limited

Original Applicant
11
Dublin IE

Nogra Pharma Limited

Owner at Publication
11
Dublin IE

Legal Representation

Attorney
Jacqueline M. Stelling

USPTO Deadlines

Next Deadline
123 days remaining
NOA E-Mailed - SOU Required
Due Date
November 20, 2025
Extension Available
Until May 20, 2026

Application History

15 events
Date Code Type Description Documents
May 20, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 1, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 28, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 28, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 27, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 26, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 3, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparation, namely aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

Additional Information

Design Mark
The mark consists of the stylized wording MEZAVANT in teal green with a lime green circle in the center of the second "a". A multi-circle loop design appears above the letters AVAN in lime green.
Color Claim
The color(s) teal green and lime green is/are claimed as a feature of the mark.

Classification

International Classes
005